<div id="readability-page-1">11:29 AM EST, 12/03/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were gaining Wednesday morning, rising 0.47% to 1,640.67 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and petroleum refiner Equinor ( EQNR ) , which rose 3.3% and 2.6%, respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical companies Grifols ( GRFS ) , which were up 2.5% and 2.1% respectively.From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which fell 6% and 3.8% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and software firm Endava ( DAVA ) , which were down 3.7% and 3.3% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Trinity Biotech ( TRIB ) , which dropped 14% and 2% respectively. They were followed by internet advertising firm Criteo (CRTO) and lender Lloyds Banking Group ( LYG ) , which lost 1.4% and 0.7% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AUTL

AKTX

NCNA

European equities traded in the US as ADRs rose 0.47% on the S&P Europe Select ADR Index. Leading gainers included Sequans Communications and Equinor, while Autolus Therapeutics and NuCana led decliners. Akari Therapeutics and Trinity Biotech also saw significant drops. MT Newswires cautions against unauthorized reproduction.

European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading